NCT05532475View on ClinicalTrials.gov

Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

March 12, 2022

Primary Completion Date

October 20, 2022

Study Completion Date

October 30, 2022

Conditions
Retinal Vein Occlusion
Interventions
DIAGNOSTIC_TEST

measurement of vitreous level of tumor necrosis factor alpha

measurement of vitreous level of tumor necrosis factor alpha using ELISA technique

Trial Locations (1)

12916

Kasr ALainy University hospital, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER